Pediatric and Ambulatory Research in Infectious Diseases

NCT ID: NCT04471493

Last Updated: 2024-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

400000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-26

Study Completion Date

2030-08-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

107 pediatricians among the 1400 members of the French ambulatory pediatric association, AFPA (Association Française de Pédiatrie Ambulatoire) were involved in this survey.To belong to the PARI network, pediatricians have to use the same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France) for electronic medical record of children. The pediatricians were trained to the use of point of care tests and to the infectious diagnoses (otitis, pharyngitis, varicella, bronchiolitis, influenza, pneumonia, etc..). The study population consisted of all children under 16 years of age from the patient population for which an infectious disease was diagnosed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Otitis Bronchiolitis Influenza Pharyngitis Varicella Pneumonia Gastroenteritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children under 16 years of age with at least one infectious disease among:
* pharyngitis
* otitis
* pneumonia
* influenza
* bronchiolitisz
* varicella
* gastroenteritis
* enterovirus disease
* bordetella pertussis disease
* using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)

Exclusion Criteria

* parental refusal
Minimum Eligible Age

1 Day

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AFPA (Association Française de Pédiatrie Ambulatoire)

UNKNOWN

Sponsor Role collaborator

GlaxoSmithKline

INDUSTRY

Sponsor Role collaborator

Sanofi

INDUSTRY

Sponsor Role collaborator

Pfizer

INDUSTRY

Sponsor Role collaborator

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role collaborator

Association Clinique Thérapeutique Infantile du val de Marne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Cohen

Role: STUDY_DIRECTOR

Association Clinique et Thérapeutique Infantile du Val de Marne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AFPA

Créteil, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Corinne LEVY, MD

Role: CONTACT

0033148850404

Stéphane Béchet, MSc

Role: CONTACT

0033148850404

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Corinne Levy, MD

Role: primary

0033148850404

Stéphane Béchet, MSc

Role: backup

0033148850404

References

Explore related publications, articles, or registry entries linked to this study.

Cohen R, Bechet S, Gelbert N, Frandji B, Vie Le Sage F, Thiebault G, Kochert F, Cahn-Sellem F, Werner A, Ouldali N, Levy C. New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era. Pediatr Infect Dis J. 2021 Jul 1;40(7):674-680. doi: 10.1097/INF.0000000000003116.

Reference Type DERIVED
PMID: 33657594 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/33657594/

New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era

https://pubmed.ncbi.nlm.nih.gov/36034052/

Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACT0116

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Viral Respiratory Infections
NCT06764381 NOT_YET_RECRUITING